Display options
Cite
Connick JH, Stone TW. Quinolinic acid effects on amino acid release from the rat cerebral cortex in vitro and in vivo. Br J Pharmacol. 1988;93(4):868-76doi: 10.1111/j.1476-5381.1988.tb11474.x.
Connick, J. H., & Stone, T. W. (1988). Quinolinic acid effects on amino acid release from the rat cerebral cortex in vitro and in vivo. British journal of pharmacology, 93(4), 868-76. https://doi.org/10.1111/j.1476-5381.1988.tb11474.x
Connick, J H, and Stone, T W. "Quinolinic acid effects on amino acid release from the rat cerebral cortex in vitro and in vivo." British journal of pharmacology vol. 93,4 (1988): 868-76. doi: https://doi.org/10.1111/j.1476-5381.1988.tb11474.x
Connick JH, Stone TW. Quinolinic acid effects on amino acid release from the rat cerebral cortex in vitro and in vivo. Br J Pharmacol. 1988 Apr;93(4):868-76. doi: 10.1111/j.1476-5381.1988.tb11474.x. PMID: 2898959; PMCID: PMC1853900.
Copy Download .nbib Format: NLM
Share it on
Full text links
Wiley Free PMC Article

Br J Pharmacol. 1988 Apr;93(4):868-76. doi: 10.1111/j.1476-5381.1988.tb11474.x.

Quinolinic acid effects on amino acid release from the rat cerebral cortex in vitro and in vivo.

British journal of pharmacology

J H Connick, T W Stone

Affiliations

  1. Department of Physiology, St George's Hospital Medical School, London.

PMID: 2898959 PMCID: PMC1853900 DOI: 10.1111/j.1476-5381.1988.tb11474.x
Free PMC Article

Abstract

1. The effect of quinolinic acid, N-methyl-D,L-aspartate (NMDLA) and kainate on the release of endogenous and exogenous amino acids from the rat cerebral cortex in vitro and in vivo was studied. 2. Neither quinolinic acid nor NMDLA had any effect on the basal or potassium-evoked release of [3H]-D-aspartate from slices of rat cerebral cortex either in the presence or absence of magnesium. Kainic acid failed to modify the basal efflux of [3H]-D-aspartate but significantly inhibited (by 34.4% +/- 0.04%, P less than 0.05) the potassium-evoked release. 3. Neither quinolinate nor NMDLA had any effect on the basal efflux of endogenous amino acids from rat cortical slices either in the presence or absence of magnesium ions at concentrations between 10 microM and 5 mM. 4. Both NMDLA (1 mM) and quinolinate (5 mM) produced an efflux of endogenous aspartate (371.4% +/- 11.6%; 389.3% +/- 12.1%) and glutamate (405.4% +/- 13.6%; 430.1 +/- 8.7%) respectively from the rat cerebral cortex in vivo (P less than 0.01). The quinolinic acid-evoked efflux was abolished by the NMDLA antagonist, 2-amino-5-phosphonovaleric acid (200 microM). 5. Kainic acid also caused an efflux of endogenous amino acids from the rat cerebral cortex in vivo. However, the profile of this release was different from that produced by quinolinate and NMDLA. 6. The results add further support to the suggestion that quinolinic acid acts at the NMDLA-preferring receptor and may also explain the requirement for intact afferent projections for the neurotoxic effects of quinolinate to be manifested.

Similar articles

Cited by

References

  1. Anal Chem. 1971 Jun;43(7):880-2 - PubMed
  2. J Biol Chem. 1951 Nov;193(1):265-75 - PubMed
  3. J Physiol. 1976 Nov;262(2):383-400 - PubMed
  4. Experientia. 1977 Apr 15;33(4):489-91 - PubMed
  5. Neuroscience. 1979;4(8):1015-36 - PubMed
  6. Epilepsia. 1981 Jun;22(3):257-65 - PubMed
  7. Clin Chem. 1982 Mar;28(3):527-31 - PubMed
  8. Crit Rev Toxicol. 1982 Mar;10(1):1-26 - PubMed
  9. Neuropharmacology. 1982 Sep;21(9):857-60 - PubMed
  10. Science. 1983 Jan 21;219(4582):316-8 - PubMed
  11. J Neurochem. 1983 May;40(5):1314-20 - PubMed
  12. J Pharmacol Exp Ther. 1983 May;225(2):399-406 - PubMed
  13. Br J Pharmacol. 1983 Oct;80(2):263-7 - PubMed
  14. Eur J Pharmacol. 1983 Dec 9;96(1-2):111-5 - PubMed
  15. Brain Res. 1984 May 7;299(1):103-12 - PubMed
  16. Life Sci. 1984 Jul 2;35(1):19-32 - PubMed
  17. J Pharmacol Exp Ther. 1985 Apr;233(1):254-63 - PubMed
  18. J Neurochem. 1985 Aug;45(2):335-44 - PubMed
  19. J Neurochem. 1985 Oct;45(4):1172-7 - PubMed
  20. Neuroscience. 1985 Jul;15(3):597-617 - PubMed
  21. Brain Res. 1985 Dec 2;348(2):289-96 - PubMed
  22. Eur J Pharmacol. 1986 Mar 4;121(3):337-43 - PubMed
  23. Biochem Pharmacol. 1986 Oct 15;35(20):3631-5 - PubMed
  24. Nat New Biol. 1973 Feb 14;241(111):201-4 - PubMed

Substances

MeSH terms

Publication Types

LinkOut - more resources